Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A1 | P13866 | 17/20 | 0.48 |
| ▸ | SLC5A2 | P31639 | 17/20 | 0.48 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13764510 | 0.85 | SLC5A1 (0.47) | SLC5A1SLC5A2 | |
| SCHEMBL13764492 | 0.84 | SLC5A2 (0.49) | SLC5A1SLC5A2 | |
| SCHEMBL13764493 | 0.83 | SLC5A2 (0.48) | SLC5A1SLC5A2 | |
| SCHEMBL13764506 | 0.82 | SLC5A2 (0.46) | SLC5A1SLC5A2SLC28A3 | |
| SCHEMBL13764504 | 0.82 | SLC5A1 (0.45) | SLC5A1SLC5A2SLC28A3 | |
| SCHEMBL1728381 | 0.80 | SLC5A2 (0.54) | SLC5A1SLC5A2SLC28A3 | |
| SCHEMBL1728328 | 0.79 | SLC5A2 (0.69) | SLC5A1SLC5A2 | |
| SCHEMBL1728250 | 0.79 | SLC5A2 (0.60) | SLC5A1SLC5A2 | |
| SCHEMBL1728293 | 0.79 | SLC5A2 (0.59) | SLC5A1SLC5A2 | |
| SCHEMBL1726679 | 0.79 | SLC5A2 (0.54) | SLC5A1SLC5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7566699-B2 | Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2009-07-28 | — | — | US | disclosed |
| US-7566699-B2 | Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2009-07-28 | — | — | US | disclosed |